ScholarIQanswers from OpenAlex
Centre Eugène Marquis
InstitutionResearch output, impact & collaborations
Centre Eugène Marquis is a institution indexed in ScholarIQ from OpenAlex.
What is known about Centre Eugène Marquis?
ScholarIQrecord summary
Centre Eugène Marquis is a research organisation in Rennes, FR. OpenAlex records 3,890 works and 256,029 citations for it. 679 researchers list it as their most recent affiliation.
How many works does Centre Eugène Marquis have?
ScholarIQindexed works
Centre Eugène Marquis has 3,890 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Centre Eugène Marquis have?
ScholarIQcitation count
Centre Eugène Marquis has 256,029 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Centre Eugène Marquis?
ScholarIQresearcher count
Centre Eugène Marquis has 679 researchers in the ScholarIQ index.
What is the average h-index at Centre Eugène Marquis?
ScholarIQavg h-index
Centre Eugène Marquis has an average h-index of 85 in OpenAlex.
What is the ROR of Centre Eugène Marquis?
ScholarIQror
The ROR for Centre Eugène Marquis is on the source record.
What is the OpenAlex record for Centre Eugène Marquis?
ScholarIQopenalex
The OpenAlex for Centre Eugène Marquis is on the source record.
Who are the most-cited researchers behind Centre Eugène Marquis?
ScholarIQtop researchers by citations
What are the most-cited papers on Centre Eugène Marquis?
ScholarIQmost cited works
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam Brufsky, Sagar Sardesai, Kevin Kalinsky, Amelia Zelnak, Robert Weaver, Tiffany A. Traina, Florence Dalenc, Philippe Aftimos, Filipa Lynce, Sami Diab, Javier Cortés, Joyce O’Shaughnessy, Véronique Dièras, Cristiano Ferrario, Peter Schmid, Lisa A. Carey, Luca Gianni, Martine Piccart, Sibylle Loibl, David M. Goldenberg, Quan Hong, Martin Olivo, Loretta M. Itri, Hope S. Rugo
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Fátima Cardoso, Elżbieta Senkus, A. Costa, Efthymios Papadopoulos, Matti Aapro, Fabrice André, Nadia Harbeck, B. Aguilar Lopez, C.H. Barrios, Jonas Bergh, Laura Biganzoli, C.B. Boers-Doets, Maria João Cardoso, L.A. Carey, Javier Cortés, Giuseppe Curigliano, Véronique Dièras, Nagi S. El Saghir, Alexandru Eniu, Lesley Fallowfield, P.A. Francis, Karen A. Gelmon, S. Johnston, Bella Kaufman, Smruti Koppikar, I.E. Krop, Musa Mayer, Gertrude Nakigudde, B.V. Offersen, Shinji Ohno, Olivia Pagani, Shani Paluch–Shimon, Frédérique Penault‐Llorca, Aleix Prat, H.S. Rugo, G. W. Sledge, Danielle Spence, Christoph Thomssen, D.A. Vorobiof, B. Xu, Larry Norton, E.P. Winer
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Nicholas J. Robert, Véronique Dièras, John A. Glaspy, Adam Brufsky, Igor Bondarenko, Oleg Lipatov, Edith A. Perez, Denise A. Yardley, Stephen Chan, Xian Zhou, S. Phan, Joyce O’Shaughnessy
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer
Maura N. Dickler, Sara M. Tolaney, Hope S. Rugo, Javier Cortés, Véronique Dièras, Debra A. Patt, Hans Wildiers, Clifford A. Hudis, Joyce O’Shaughnessy, Esther Zamora, Denise A. Yardley, Martin Frenzel, Andrew Koustenis, José Baselga
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Aditya Bardia, Sara M. Tolaney, Kevin Punie, Delphine Loirat, Mafalda Oliveira, Kevin Kalinsky, Amelia Zelnak, Philippe Aftimos, Florence Dalenc, Sagar Sardesai, Erika Hamilton, Priyanka Sharma, Sabela Recalde, Eva Ciruelos Gil, T Traina, Joyce O’Shaughnessy, Javier Cortés, Mu‐Hung Tsai, Linda T. Vahdat, Véronique Dièras, Lisa A. Carey, Hope S. Rugo, David M. Goldenberg, Q. Hong, Martin Olivo, Loretta M. Itri, Sara A. Hurvitz
How much of the research on Centre Eugène Marquis is open access?
ScholarIQopen access share
57%OPEN ACCESS